Rajangam Kanya
SEC insider (Form 3/4/5 filer). CIK 0001816676. Pres. & Chief Med. & Dev. Off. at Senti Biosciences Holdings, Inc. (SNTI). 10 reported Form 4/5 transactions since Sep 2024; latest on Oct 21, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Rajangam Kanya has filed insider reports for
- Senti Biosciences Holdings, Inc. (SNTI): Officer, Pres. & Chief Med. & Dev. Off.
Rajangam Kanya
CIK: 0001816676
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Senti Biosciences Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Oct 21, 2026SNTI
Senti Biosciences Holdings, Inc.
Tax PaymentDirect20K shares- - Mar 9, 2026SNTI
Senti Biosciences, Inc.
Tax PaymentDirect10.8K shares- - Feb 2, 2026SNTI
Senti Biosciences, Inc.
Tax PaymentDirect1.4K shares- - Mar 10, 2025SNTI
Senti Biosciences, Inc.
ConversionIndirect33K shares at avg. $2.25$74K - Mar 7, 2025SNTI
Senti Biosciences, Inc.
AwardDirect78.4K shares- - Mar 6, 2025SNTI
Senti Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
235.1K shares- - Feb 6, 2025SNTI
Senti Biosciences, Inc.
SaleDirect182 shares at avg. $4.37$795.34 - Feb 4, 2025SNTI
Senti Biosciences, Inc.
SaleDirect1.3K shares at avg. $4.07$5K - Dec 9, 2024SNTI
Senti Biosciences, Inc.
AwardIndirectSeries A Convertible Preferred Stock
33 shares at avg. $2250.00- - Dec 9, 2024SNTI
Senti Biosciences, Inc.
AwardIndirectCommon Stock Warrant (right to buy)
49.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 | SNTI Senti Biosciences Holdings, Inc. | Tax Payment | 19,953 | - | $0 | Direct |
| Mar 9, 2026 | SNTI Senti Biosciences, Inc. | Tax Payment | 10,757 | - | $0 | Direct |
| Feb 2, 2026 | SNTI Senti Biosciences, Inc. | Tax Payment | 1,384 | - | $0 | Direct |
| Mar 10, 2025 | SNTI Senti Biosciences, Inc. | Conversion | 33,000 | $2.25 | $74,250 | Indirect |
| Mar 7, 2025 | SNTI Senti Biosciences, Inc. | Award | 78,363 | - | - | Direct |
| Mar 6, 2025 | SNTI Senti Biosciences, Inc. | Award Stock Option (Right to Buy) | 235,088 | - | - | Direct |
| Feb 6, 2025 | SNTI Senti Biosciences, Inc. | Sale | 182 | $4.37 | $795 | Direct |
| Feb 4, 2025 | SNTI Senti Biosciences, Inc. | Sale | 1,297 | $4.07 | $5,279 | Direct |
| Dec 9, 2024 | SNTI Senti Biosciences, Inc. | Award Series A Convertible Preferred Stock | 33 | $2250.00 | - | Indirect |
| Dec 9, 2024 | SNTI Senti Biosciences, Inc. | Award Common Stock Warrant (right to buy) | 49,500 | - | - | Indirect |
1-10 of 10 transactions